+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microrna"

From
From
From
From
From
From
From
From
From
From
From
From
From
RNAi - Technologies, Markets & Companies - Product Thumbnail Image

RNAi - Technologies, Markets & Companies

  • Report
  • November 2021
  • 527 Pages
  • Global
From
DNA Sequencing - Technologies, Markets & Companies - Product Thumbnail Image

DNA Sequencing - Technologies, Markets & Companies

  • Report
  • November 2021
  • 545 Pages
  • Global
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
  • Global
From
Personalized Medicine - Scientific & Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific & Commercial Aspects

  • Report
  • November 2021
  • 1165 Pages
  • Global
From
Cytogenetics - Technologies, Markets & Companies - Product Thumbnail Image

Cytogenetics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 233 Pages
  • Global
From
Loading Indicator

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more